Study_No,Group,Pharmacy,Disease,Disease_Dur,Age,Gender,Ethnicity,updrs1_base,updrs1_tre1,updrs2_base,updrs2_tre1,updrs3_base,updrs3_tre1,brady_base,brady_tre1
1,excluded,,,,,,,-99,,,,,,,
2,0,1-PD,PD,3,79,1,w,15,9,14,11,32,24,13.5,11
3,1,2-PD,PD,9,64,1,w,9,9,15,15,23,23,5,5
4,0,3-PD,PD,5,53,2,w,15,15,13,13,26,23,7,7
5,1,4-PD,PD,17,71,1,a,16,16,23,23,23,23,6,6
6,0,5-PD,PD,5,56,2,w,15,16,28,28,41,52,17,23
7,0,6-PD,PD,7,66,2,w,8,14,3,3,14,7,7,2
8,1,7-PD,PD,6,66,1,w,2,2,1,3,13,1,4,0
9,1,8-PD,PD,4,64,2,w,9,5,4,3,12,6,2,3
10,0,9-PD,PD,3,56,1,w,11,10,19,16,25,41,13,17
11,1,10-PD,PD,4,65,2,w,12,12,31,32,75,73,34,34
12,1,11-PD,PD,2,60,1,w,11,6,7,4,35,23,17,8
13,0,12-PD,PD,8,63,1,w,6,8,15,13,52,36,29,17
14,excluded,,,,,,,,,,,,,,
15,1,14-PD,PD,10,66,1,w,9,7,12,8,35,22,17,8
16,1,1-MSA,MSA,2,50,1,w,9,8,18,20,36,34,20,18